Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper
- 31 December 1992
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 97 (2-3) , 209-216
- https://doi.org/10.1016/0021-9150(92)90133-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A 21-aminosteroid inhibits oxidation of human low density lipoprotein by human monocytes and copperAtherosclerosis, 1991
- Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemiaThe American Journal of Cardiology, 1991
- β-Carotene inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Oxidation of low-density lipoprotein by copper and iron in phosphate bufferBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Calcium Antagonists Prevent Monocyte and Endothelial Cell-Induced Modification of Low Density LipoproteinsFree Radical Research Communications, 1991
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptorsJournal of Molecular and Cellular Cardiology, 1989
- Superoxide initiates oxidation of low density lipoprotein by human monocytes.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- A Pharmacokinetic Study of Carvedilol (BM 14.190) in Elderly SubjectsJournal of Cardiovascular Pharmacology, 1987
- Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.Journal of Clinical Investigation, 1986